6 completed, 2 terminated, 2 unknown, 1 recruiting. 11 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Completed 6, Terminated 2, Unknown 2, Recruiting 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Unknown 1 |
Follow Tinzaparin: new trials by email Literature Review of Tinzaparin trials Research Report on Tinzaparin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer Tinzaparin Injectable Solution - Epithelial Ovarian Cancer | Phase 2 | Recruiting | University Hospital, Linkoeping | 40 | 2022-07-12 | 2026-05-11 |
| ANTIcoagulation in Severe COVID-19 Patients Tinzaparin, Low dose prophylactic anticoagulation, Tinzaparin, High dose prophylactic anticoagulation, Tinzaparin,Therapeutic anticoagulation - Severe COVID-19 Pneumonia | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 353 | 2021-04-14 | 2022-09-08 |
| Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort Tinzaparin or unfractionated heparin - COVID19 Pneumonia | Phase 2 | Unknown | Assistance Publique - Hôpitaux de Paris | 808 | 2020-04-20 | 2020-04-15 |
| Study of Rivaroxaban for CeREbral Venous Thrombosis Rivaroxaban, Standard of care - Cerebral Venous Thrombosis | Phase 2 | Completed | University of British Columbia | 55 | 2019-03-12 | 2022-12-14 |
| Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer Tinzaparin, Blood sample - Lymphoma, Multiple Myeloma | Phase 2 | Completed | Centre Hospitalier Universitaire de Saint Etienne | 19 | 2015-04-14 | 2017-05-11 |
| Anticoagulation Length in Cancer Associated Thrombosis Low Molecular Weight Heparin (LMWH) - Cancer, Thrombosis | Phase 2 | Terminated | Cardiff University | 2 | 2013-12-01 | 2018-10-29 |
| Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery tinzaparin sodium - Kidney Cancer | Phase 1 / Phase 2 | Unknown | University of Vermont | 35 | 2005-12-01 | 2013-11-06 |
| Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer Tinzaparin sodium - Venous Thromboembolism, Cancer | Phase 2 | Terminated | University of Southern California | 131 | 2005-07-01 | 2017-07-06 |
| A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery Fragmin (dalteparin), Innohep (tinzaparin) - Thromboembolism, Hemodialysis | Phase 2 / Phase 3 | Completed | Ottawa Hospital Research Institute | 29 | 2003-10-01 | 2014-09-10 |
| Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST) Aspirin, tinzaparin sodium, eptifibatide - Ischemic Stroke | Phase 2 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 18 | 2003-05-01 | 2013-02-04 |
| The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section Tinzaparin - Deep Vein Thrombosis | Phase 2 / Phase 3 | Completed | Ottawa Hospital Research Institute | 30 | 2002-07-01 | 2018-02-07 |
Neoplasms (2) · Venous Thromboembolism (2) · Venous Thrombosis (2) · COVID-19 (1) · Carcinoma, Ovarian Epithelial (1) · Carcinoma, Renal Cell (1) · Hemorrhage (1) · Intracranial Thrombosis (1) · Ischemic Stroke (1) · Kidney Failure, Chronic (1) · Kidney Neoplasms (1) · Lymphoma (1) · Multiple Myeloma (1) · Pulmonary Embolism (1) · Thromboembolism (1)
Assistance Publique - Hôpitaux de Paris (2) · Ottawa Hospital Research Institute (2) · Cardiff University (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · University Hospital, Linkoeping (1) · University of British Columbia (1) · University of Southern California (1) · University of Vermont (1)
Canada (3) · France (3) · United States (3) · Sweden (1) · United Kingdom (1)
Anna Karlsson, MD (1) · Anna-Clara Spetz Holm, MD, PhD (1) · Deborah L. Ornstein, MD (1) · Gabriel Lindahl, MD, PhD (1) · Marc Rodger, MD (1) · Marc Rodger, MD, MSc (1) · Simon Noble, Dr (1) · Steven Warach, MD, PhD (1) · Thalia S Field, MD FRCPC (1)
PMID 16458642, PMID 26490434, PMID 33502773, PMID 33779986, PMID 35244208, PMID 35473740, PMID 36946232, PMID 37675613, PMID 38189593
2014 (1)